|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,155.00 TWD | -3.35% |
|
+8.96% | +145.74% |
| 06-18 | PharmaEssentia Rebuffs Media Report Speculating Profit, Revenue for 2026 | MT |
| 06-11 | PharmaEssentia Completes Enrollment for Phase III Primary Myelofibrosis Drug Study | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 1,195 | 1,195 | 1,279.59 |
| Spread/Res. | -3.35% | -3.35% | -9.74% |
| Spread/Supp. | +16.67% | +46.39% | +59.31% |
| Support | 990 | 789 | 725 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- 6446 Stock
- Charts PharmaEssentia Corporation
Select your edition
All financial news and data tailored to specific country editions
